Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
The American Journal of Gastroenterology
|
July 31, 2024
Response to Li et al
Cheng-Hao Tseng, Han-Mo Chiu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 24, 2019
Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Hepatology International
|
August 15, 2020
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on
Cheng-Hao Tseng, Mindie H Nguyen, Yao-Chun Hsu
The Lancet. Gastroenterology & Hepatology
|
January 14, 2021
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply
Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 22, 2021
Reply
Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguyen
Clinical and Molecular Hepatology
|
March 14, 2023
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Seminars in Liver Disease
|
June 23, 2021
Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective
Yao-Chun Hsu, Cheng-Hao Tseng, Yen-Tsung Huang, et al.
Gut
|
February 24, 2010
A 61-year-old man with abdominal pain for 6 months
Cheng-Hao Tseng, Jyh-Ming Liou, Kao-Lang Liu, et al.
Digestive Diseases (Basel, Switzerland)
|
September 15, 2020
Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis
Cheng-Hao Tseng, Yao-Chun Hsu, Hsiu J Ho, et al.
Gut
|
October 21, 2021
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
The American Journal of Gastroenterology
|
July 31, 2024
Response to Li et al
Cheng-Hao Tseng, Han-Mo Chiu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 24, 2019
Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Hepatology International
|
August 15, 2020
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on
Cheng-Hao Tseng, Mindie H Nguyen, Yao-Chun Hsu
The Lancet. Gastroenterology & Hepatology
|
January 14, 2021
Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B - Authors' reply
Cheng-Hao Tseng, Yao-Chun Hsu, Mindie H Nguyen
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 22, 2021
Reply
Yao-Chun Hsu, Cheng-Hao Tseng, Mindie H Nguyen
Clinical and Molecular Hepatology
|
March 14, 2023
Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Seminars in Liver Disease
|
June 23, 2021
Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective
Yao-Chun Hsu, Cheng-Hao Tseng, Yen-Tsung Huang, et al.
Gut
|
February 24, 2010
A 61-year-old man with abdominal pain for 6 months
Cheng-Hao Tseng, Jyh-Ming Liou, Kao-Lang Liu, et al.
Digestive Diseases (Basel, Switzerland)
|
September 15, 2020
Increasing Age and Nonliver Comorbidities in Patients with Chronic Hepatitis B in Taiwan: A Nationwide Population-Based Analysis
Cheng-Hao Tseng, Yao-Chun Hsu, Hsiu J Ho, et al.
Gut
|
October 21, 2021
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, et al.
Page
of 10